HealthDay News — There has been a rise in fabricated references utilized in medical papers, in keeping with a analysis letter revealed within the May 9 difficulty of The Lancet.
Maxim Topaz, Ph.D., from Columbia University in New York City, and colleagues developed an automatic reference verification system scanning PubMed Central’s Open Access subset from Jan. 1, 2023, to Feb. 18, 2026, together with 2,471,758 papers and 125,615,773 structured references. References have been extracted from full-text extensible markup language, retaining these with a PubMed identifier (PMID).
The researchers discovered that 97.1 million of the 125.6 million references carried a PMID and have been verified; the remaining 23 p.c have been excluded. References passing all filters have been verified; these not present in any database have been labeled as fabricated. Of the 97.1 million verified references, 4,046 references throughout 2,810 papers have been recognized as fabricated. Approximately one in 2,828 papers contained at the least one fabricated reference in 2023; this elevated to at least one in 458 by 2025 and one in 277 papers within the first seven weeks of 2026. The fabrication charge elevated from about 4 per 10,000 papers in 2023 to 51.3 per 10,000 papers within the fourth quarter of 2025, reaching 56.9 per 10,000 papers in early 2026.
“A medical professional or clinical guideline developer has no way of knowing that the evidence they are relying on does not exist. For example, one paper we reviewed had 18 out of 30 fake references,” Topaz stated in a press release. “Some of those citations are already being cited by other papers and appear in systematic reviews that inform clinical care.”